Events

Events Search and Views Navigation

Event Views Navigation

Today

  • Designing the AI-Enabled Life Sciences Workforce Summit Europe

    Essential by Dorint Basel City Schönaustrasse 10, Switzerland, Basel, Switzerland

    AI is no longer a future concept in life sciences – it is actively reshaping how work gets done, how decisions are made, and how value is created. Yet most […]

  • 5th mRNA Process Development & CMC Summit 2026

    Wyndham Boston Beacon Hill 5 Blossom St, Boston, MA, United States

    The mRNA Process Development & CMC Summit returns for its 5th Anniversary, bringing together the brightest minds in mRNA development, manufacturing, and CMC strategy. As the field continues to evolve […]

  • 16th World Clinical Biomarkers & Companion Diagnostics Summit

    The Westin Boston Seaport District 425 Summer Street, Boston, MA, United States

    Fueled by surging digital pathology partnerships, improved MRD sensitivity and high-plex single‑cell and multi‑omic profiling to breakthroughs, the precision medicine field is evolving rapidly. Building on this momentum, the 16th […]

  • 17th World ADC San Diego

    Town & Country San Diego 500 Hotel Circle, North San Diego, San Diego, CA, United States

    Returning as the largest and definitive ADC congress, the 17th World ADC San Diego is THE one-stop bioconjugate shop, bringing together the global ADC community for an unparalleled amalgamation of […]

  • 5th Operationalise: Early Access Programmes Summit Europe

    Park Plaza Victoria London 239 Vauxhall Bridge Road Pimlico, London, United Kingdom

    Early Access Programmes have evolved into a critical, but increasingly complex, part of drug development and launch strategy. What was once a reactive pathway is now a strategic lever shaping […]

  • 9th TPD & Induced Proximity Summit

    The Omni Boston Hotel at the Seaport 450 Summer Street, Boston, MA, United States

    After a decade of innovation, the TPD field has its first drug approval in the form of Arvinas’ Veppanu. Combined with the recovering market of 2026, this clinical validation will […]